Descripción general del mercado de servicios de detección y análisis de colesterol
Se espera que el mercado de servicios de detección de colesterol/pruebas de colesterol crezca a una tasa de crecimiento anual compuesta del 7,9% entre 2023 y 2030. Se espera que alcance más de 33 150 millones de dólares en 2030, frente a los 19 470 millones de dólares en 2023. Todas las células de nuestro cuerpo contienen colesterol, una sustancia cerosa y grasa. Si el nivel de colesterol en sangre es demasiado alto, puede unirse a otros componentes
de la sangre para producir placa, que se adhiere al revestimiento de las arterias. Otro nombre para una prueba de colesterol completa es panel de lípidos o perfil de lípidos. Su médico puede utilizarlo para evaluar los niveles de colesterol "bueno" y "malo", así como una forma de grasa llamada triglicéridos en la sangre. Con el aumento de la prevalencia de enfermedades cardiovasculares y obesidad, se prevé que el mercado de servicios de pruebas de colesterol a nivel mundial tenga un crecimiento considerable en los próximos años. Además del aumento del conocimiento y la adopción de la atención sanitaria preventiva, otro factor que impulsará el mercado es la preferencia de los médicos por las pruebas de laboratorio en lugar de las pruebas realizadas por uno mismo. Las acciones del gobierno también aumentarán la calidad de las pruebas. Además, la prevalencia de enfermedades cardiovasculares aumentará debido al aumento de la población de personas mayores en todo el mundo. Además, el aumento del gasto
en atención médica y el aumento de la conciencia pública sobre las enfermedades cardiovasculares, sus causas, tratamiento y prevención también impulsan el crecimiento del mercado. Los niveles elevados de colesterol crean amenazas para la salud, como un riesgo agudo de accidente cerebrovascular y enfermedades cardíacas, y son responsables de muchas muertes. Los servicios de detección del colesterol permiten la detección temprana de los problemas relacionados con los niveles altos de colesterol, evitando complicaciones y aumentando las posibilidades de supervivencia de los pacientes. Por otro lado, se espera que el rápido crecimiento del mercado de pruebas caseras/autoevaluadas y la aparición de métodos de prueba de colesterol no invasivos limiten el crecimiento de este mercado de servicios de prueba de colesterol hasta cierto punto. [caption id="attachment_30077" align="aligncenter" width="1920"]
Mercado de servicios de detección y análisis de colesterol | Exactitude Consultancy[/caption] La obesidad es una condición relacionada con el colesterol elevado. La necesidad de estas pruebas aumentará a medida que aumente el número de enfermedades relacionadas con el colesterol alto, lo que impulsará el mercado mundial de pruebas de colesterol en laboratorio. Los servicios de pruebas de laboratorio de colesterol ayudan a diagnosticar problemas de forma temprana, prevenir complicaciones y aumentar las probabilidades de supervivencia de los pacientes. Se espera que esto conduzca a un aumento en la demanda de pruebas de laboratorio para el colesterol. Se prevé que el segmento de las agencias gubernamentales crezca significativamente en los próximos años debido a su mayor enfoque en el tratamiento preventivo y la detección temprana para evitar problemas médicos graves. Para proporcionar servicios de pruebas de diagnóstico de primer nivel a nivel mundial, los actores clave del mercado se asocian con organizaciones afiliadas a los gobiernos federal, estatal y local. Los adultos entre 40 y 59 años tienen los niveles más altos de colesterol total. Un estilo de vida sedentario, que se ha relacionado con la aparición de varias enfermedades, incluida la obesidad, la diabetes y las enfermedades cardíacas, es el principal culpable de esto. El coronavirus del síndrome respiratorio agudo severo es el culpable de la actual epidemia de la enfermedad por coronavirus-19 (COVID-19). Cuando se infecta con el coronavirus 2 del síndrome respiratorio agudo severo (SARS-CoV-2) que causa la enfermedad por coronavirus-19, los pacientes con enfermedad cardiovascular (ECV), hipertensión y sobrepeso/obesidad suelen tener un curso clínico más grave (COVID-19). Este riesgo aumenta a medida que las arterias se estrechan debido a una acumulación de colesterol malo. El tipo de placa conocida como placa impide que la sangre llegue y salga del corazón y otros órganos. El colesterol alto se ha relacionado con una mayor probabilidad de contraer varias enfermedades. Incluso hay algunas pruebas de que algunos pacientes con COVID-19 experimentan una mayor mortalidad como resultado de tener niveles elevados de colesterol. Después de la pandemia de COVID-19, las personas están engordando y tienen más probabilidades de contraer enfermedades cardiovasculares.
ATRIBUTO |
DETALLES |
Periodo de estudio |
2020-2030 |
Año base |
2022 |
Año estimado |
2023 |
Año pronosticado |
2023-2030 |
Periodo histórico |
2019-2021 |
Unidad |
Valor (miles de millones de USD) |
Segmentación |
Por tipo de cliente, por región |
Por tipo de cliente |
- Médicos/Proveedores y Hospitales
- Agencias gubernamentales
- Centros de diagnóstico
- Pacientes
- Otros
|
Por región
|
- América del norte
- Asia Pacífico
- Europa
- Sudamerica
- Oriente Medio, Asia y África
|
Cholesterol Screening/ Cholesterol Testing Services Market Segment Analysis
Cholesterol screening/ cholesterol testing services market is segmented based on type of customer, and region.
Based on type of customer, a significant portion of the market was made up of diagnostic centers. Providing patients with a variety of diagnostic tests, such as cholesterol screening, is a specialty of diagnostic centers. These institutions frequently contain cutting-edge laboratories, knowledgeable staff, and specialized tools to carry out various tests quickly and accurately. A few factors have contributed to the rise in popularity of diagnostic centers in recent years. In comparison to hospitals, they typically have lower wait periods and convenient access to diagnostic procedures. Additionally, diagnostic centers might offer specialized services that are just focused on diagnostic testing, enabling them to provide patients seeking cholesterol screening with a streamlined and effective experience. Hospitals and clinics, in addition to diagnostic facilities, are essential in the delivery of services for cholesterol screening and testing. To suit the needs of their patients, these healthcare facilities frequently have their own internal laboratories or may work with other diagnostic facilities.
[caption id="attachment_30112" align="aligncenter" width="1920"]
Cholesterol Screening/ Cholesterol Testing Services Market | Exactitude Consultancy[/caption]
Cholesterol Screening/ Cholesterol Testing Services Market Players
The cholesterol screening/ cholesterol testing services market key players include
ACM Medical Laboratory, Clinical Reference Laboratory, Inc., Laboratory Corporation of America Holdings, Eurofins Scientific, Quest Diagnostics Incorporated, SYNLAB International GmbH, Fresenius Medical Care Holdings, Inc., Spectra Laboratories Inc., Unilabs, Bio-Reference Laboratories Inc.
Recent News:
- On June 2021, ACM Global Laboratories, Inc. is pleased to announced the rebranding of ABS Laboratories to ACM Bioanalytical Services. Founded over two decades ago by Drs. Colin Feyerabend and Mira Doig, ABS Laboratories was purchased by ACM Global Laboratories in 2018 as it expanded its central laboratory testing offerings for clinical trials to include bioanalytical services. ABS Laboratories, now ACM Bioanalytical Services, specialised in complex assay development and validation for the quantification of drugs, metabolites and biomarkers in biological samples used in pharmaceutical research and development.
- On February 2021, Clinical Reference Laboratory (CRL), one of the largest privately held clinical testing laboratories in the U.S., and Walgreens announced that the FDA-authorized CRL Rapid Response COVID-19 Saliva Test is available through Walgreens Find Care®, a digital health platform available on the Walgreens app and Walgreens.com. Sold under CRL's HealthConfirm® brand, the COVID-19 Saliva Test is non-invasive and highly accurate, offered consumers the convenience of self-collecting the test right in their homes without supervision.
Cholesterol Screening/ Cholesterol Testing Services Market Regional Analysis
The cholesterol screening/ cholesterol testing services market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN, and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina, and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
In terms of revenue, North America holds a significant portion of the worldwide market and is expected to continue to dominate during the forecast period. The growing senior population, which has increased the base of patients who can be served, is one of the main causes of this high percentage in North America. This modification is anticipated to increase awareness of preventative strategies like clinical diagnostics, particularly cholesterol screenings, to lower the occurrence of unpleasant events brought on by illnesses like stroke, diabetes, and cardiovascular disease. The U.S. is a significant market in North America for companies that offer cholesterol testing services.
[caption id="attachment_30114" align="aligncenter" width="1920"]
Cholesterol Screening/ Cholesterol Testing Services Market | Exactitude Consultancy[/caption]
- INTRODUCCIÓN
- DEFINICIÓN DE MERCADO
- SEGMENTACIÓN DEL MERCADO
- CRONOGRAMAS DE INVESTIGACIÓN
- SUPUESTOS Y LIMITACIONES
- METODOLOGÍA DE LA INVESTIGACIÓN
- MINERÍA DE DATOS
- INVESTIGACIÓN SECUNDARIA
- INVESTIGACIÓN PRIMARIA
- ASESORAMIENTO DE EXPERTOS EN LA MATERIA
- CONTROLES DE CALIDAD
- REVISIÓN FINAL
- TRIANGULACIÓN DE DATOS
- ENFOQUE DE ABAJO HACIA ARRIBA
- ENFOQUE DE ARRIBA HACIA ABAJO
- FLUJO DE INVESTIGACIÓN
- USUARIOS FINALES DE LOS DATOS
- RESUMEN EJECUTIVO
- PANORAMA DEL MERCADO
- PERSPECTIVA DEL MERCADO MUNDIAL DE SERVICIOS DE DETECCIÓN Y ANÁLISIS DE COLESTEROL
- IMPULSORES DEL MERCADO
- RESTRICCIONES DEL MERCADO
- OPORTUNIDADES DE MERCADO
- IMPACTO DEL COVID-19 EN EL MERCADO DE SERVICIOS DE DETECCIÓN Y ANÁLISIS DE COLESTEROL
- MODELO DE LAS CINCO FUERZAS DE PORTER
- AMENAZA DE NUEVOS INGRESANTES
- AMENAZA DE SUSTITUTOS
- PODER DE NEGOCIACIÓN DE LOS PROVEEDORES
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER OF CUSTOMER, (USD BILLION), 2020-2030
- PHYSICIANS/PROVIDERS AND HOSPITALS
- GOVERNMENT AGENCIES
- DIAGNOSTIC CENTERS
- PATIENTS
- OTHERS
- GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY REGION, (USD BILLION), 2020-2030
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- COMPANY PROFILES*
(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- ACM MEDICAL LABORATORY
- CLINICAL REFERENCE LABORATORY, INC.
- LABORATORY CORPORATION OF AMERICA HOLDINGS
- EUROFINS SCIENTIFIC
- QUEST DIAGNOSTICS INCORPORATED
- SYNLAB INTERNATIONAL GMBH
- FRESENIUS MEDICAL CARE HOLDINGS, INC.
- SPECTRA LABORATORIES INC.
- UNILABS
- BIO-REFERENCE LABORATORIES INC.
*THE COMPANY LIST IS INDICATIVE LIST OF TABLES TABLE 1 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 2 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY REGION (USD BILLION) 2022-2030
TABLE 3 NORTH AMERICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY COUNTRY (USD BILLION) 2022-2030
TABLE 4 NORTH AMERICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 5 US CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 6 CANADA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 7 MEXICO CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 8 SOUTH AMERICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY COUNTRY (USD BILLION) 2022-2030
TABLE 9 SOUTH AMERICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 10 BRAZIL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 11 ARGENTINA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 12 COLOMBIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 13 REST OF SOUTH AMERICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 14 ASIA-PACIFIC CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY COUNTRY (USD BILLION) 2022-2030
TABLE 15 ASIA-PACIFIC CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 16 INDIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 17 CHINA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 18 JAPAN CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 19 SOUTH KOREA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 20 AUSTRALIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 21 SOUTH-EAST ASIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 22 REST OF ASIA PACIFIC CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 23 EUROPE CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY COUNTRY (USD BILLION) 2022-2030
TABLE 24 EUROPE CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 25 GERMANY CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 26 UK CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 27 FRANCE CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 28 ITALY CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 29 SPAIN CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 30 RUSSIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 31 REST OF EUROPE CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 32 MIDDLE EAST AND AFRICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY COUNTRY (USD BILLION) 2022-2030
TABLE 33 MIDDLE EAST AND AFRICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 34 UAE CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 35 SAUDI ARABIA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 36 SOUTH AFRICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
TABLE 37 REST OF MIDDLE EAST AND AFRICA CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER (USD BILLION) 2022-2030
LIST OF FIGURES FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER OF CUSTOMER, USD BILLION, 2020-2030
FIGURE 9 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 10 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY TYPE OF CUSTOMER OF CUSTOMER, USD BILLION, 2022
FIGURE 11 GLOBAL CHOLESTEROL SCREENING/ CHOLESTEROL TESTING SERVICES MARKET BY REGION, USD BILLION, 2022
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 MARKET SHARE ANALYSIS
FIGURE 14 ACM MEDICAL LABORATORY: COMPANY SNAPSHOT
FIGURE 15 CLINICAL REFERENCE LABORATORY, INC.: COMPANY SNAPSHOT
FIGURE 16 LABORATORY CORPORATION OF AMERICA HOLDINGS: COMPANY SNAPSHOT
FIGURE 17 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 18 QUEST DIAGNOSTICS INCORPORATED: COMPANY SNAPSHOT
FIGURE 19 SYNLAB INTERNATIONAL GMBH: COMPANY SNAPSHOT
FIGURE 20 FRESENIUS MEDICAL CARE HOLDINGS, INC.: COMPANY SNAPSHOT
FIGURE 21 SPECTRA LABORATORIES INC.: COMPANY SNAPSHOT
FIGURE 22 UNILABS: COMPANY SNAPSHOT
FIGURE 23 BIO-REFERENCE LABORATORIES INC.: COMPANY SNAPSHOT